Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study on the Efficacy and Safety of Transdermal Delivery of Compound Betamethasone Via a Medium-Frequency Device Versus Intralesional Injection in Patients With Keloids

NCT07835438 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT07835438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07835438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study on the Efficacy and Safety of Transdermal Delivery of Compound Betamethasone Via a Medium-Frequency Device Versus Intralesional Injection in Patients With Keloids
Lead sponsor
First Hospital of China Medical University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 25, 2025
Completion date
November 29, 2026
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid